These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 29870007)
1. Binary polymorphic cocrystals: an update on the available literature in the Cambridge Structural Database, including a new polymorph of the pharmaceutical 1:1 cocrystal theophylline-3,4-dihydroxybenzoic acid. Mnguni MJ; Michael JP; Lemmerer A Acta Crystallogr C Struct Chem; 2018 Jun; 74(Pt 6):715-720. PubMed ID: 29870007 [TBL] [Abstract][Full Text] [Related]
2. The challenging case of the theophylline-benzamide cocrystal. Fischer F; Schmidt MU; Greiser S; Emmerling F Acta Crystallogr C Struct Chem; 2016 Mar; 72(Pt 3):217-24. PubMed ID: 26942431 [TBL] [Abstract][Full Text] [Related]
3. Physical stability enhancement of theophylline via cocrystallization. Trask AV; Motherwell WD; Jones W Int J Pharm; 2006 Aug; 320(1-2):114-23. PubMed ID: 16769188 [TBL] [Abstract][Full Text] [Related]
4. First-line antituberculosis drug, pyrazinamide, its pharmaceutically relevant cocrystals and a salt. Sarmah KK; Rajbongshi T; Bhowmick S; Thakuria R Acta Crystallogr B Struct Sci Cryst Eng Mater; 2017 Oct; 73(Pt 5):1007-1016. PubMed ID: 28981007 [TBL] [Abstract][Full Text] [Related]
6. Amide-N-oxide heterosynthon and amide dimer homosynthon in cocrystals of carboxamide drugs and pyridine N-oxides. Babu NJ; Reddy LS; Nangia A Mol Pharm; 2007; 4(3):417-34. PubMed ID: 17497888 [TBL] [Abstract][Full Text] [Related]
7. Exploring cocrystal-cocrystal reactivity via liquid-assisted grinding: the assembling of racemic and dismantling of enantiomeric cocrystals. Friscić T; Fábián L; Burley JC; Jones W; Motherwell WD Chem Commun (Camb); 2006 Dec; (48):5009-11. PubMed ID: 17146510 [TBL] [Abstract][Full Text] [Related]
8. Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy. Srivastava D; Fatima Z; Kaur CD Mini Rev Med Chem; 2018; 18(14):1160-1167. PubMed ID: 29512461 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of pharmaceutical cocrystals of 2,6-diaminopyridine with piracetam and theophylline. Durán-Palma MH; Mendoza-Barraza SS; Magaña-Vergara NE; Martínez-Martínez FJ; González-González JS Acta Crystallogr C Struct Chem; 2017 Oct; 73(Pt 10):767-772. PubMed ID: 28978781 [TBL] [Abstract][Full Text] [Related]
10. Halogen bonding and pharmaceutical cocrystals: the case of a widely used preservative. Baldrighi M; Cavallo G; Chierotti MR; Gobetto R; Metrangolo P; Pilati T; Resnati G; Terraneo G Mol Pharm; 2013 May; 10(5):1760-72. PubMed ID: 23514087 [TBL] [Abstract][Full Text] [Related]
11. The synthesis and characterization of a series of cocrystals of an isoniazid derivative with butan-2-one and propan-2-one. Scheepers MC; Lemmerer A Acta Crystallogr C Struct Chem; 2023 Sep; 79(Pt 9):365-373. PubMed ID: 37610289 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms by which moisture generates cocrystals. Jayasankar A; Good DJ; Rodríguez-Hornedo N Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034 [TBL] [Abstract][Full Text] [Related]
13. Cocrystals of Praziquantel with Phenolic Acids: Discovery, Characterization, and Evaluation. Yang S; Liu Q; Ji W; An Q; Song J; Xing C; Yang D; Zhang L; Lu Y; Du G Molecules; 2022 Mar; 27(6):. PubMed ID: 35335384 [TBL] [Abstract][Full Text] [Related]
14. Exploring the relationship between cocrystal stability and symmetry: is Wallach's rule applicable to multi-component solids? Friscić T; Fábián L; Burley JC; Reid DG; Duer MJ; Jones W Chem Commun (Camb); 2008 Apr; (14):1644-6. PubMed ID: 18368151 [TBL] [Abstract][Full Text] [Related]
15. Crystal structures of the pyrazinamide-p-aminobenzoic acid (1/1) cocrystal and the transamidation reaction product 4-(pyrazine-2-carboxamido)benzoic acid in the molten state. Thorat SH; Sahu SK; Gonnade RG Acta Crystallogr C Struct Chem; 2015 Nov; 71(Pt 11):1010-6. PubMed ID: 26524176 [TBL] [Abstract][Full Text] [Related]
16. Challenges in Transitioning Cocrystals from Bench to Bedside: Dissociation in Prototype Drug Product Environment. Koranne S; Sahoo A; Krzyzaniak JF; Luthra S; Arora KK; Suryanarayanan R Mol Pharm; 2018 Aug; 15(8):3297-3307. PubMed ID: 29947519 [TBL] [Abstract][Full Text] [Related]
17. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611 [TBL] [Abstract][Full Text] [Related]
18. Theophylline-nicotinamide cocrystal formation in physical mixture during storage. Ervasti T; Aaltonen J; Ketolainen J Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677 [TBL] [Abstract][Full Text] [Related]
19. Evaluating Suspension Formulations of Theophylline Cocrystals With Artificial Sweeteners. Aitipamula S; Wong ABH; Kanaujia P J Pharm Sci; 2018 Feb; 107(2):604-611. PubMed ID: 28987500 [TBL] [Abstract][Full Text] [Related]
20. Crystal structures of cocrystals of 2,7-dihydroxynaphthalene with isoniazid and piracetam. González-González JS; Valiente Flores ME; Flores-Alamo M; Macías-López E; Martínez-Martínez FJ; García-Ortega H Acta Crystallogr C Struct Chem; 2022 May; 78(Pt 5):280-286. PubMed ID: 35510433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]